The attack on opioids is intensifying once again, and the circle of companies falling victim is widening. On Aug. 1, Reuters reported that the State of Oklahoma is now making its final efforts to hold Johnson & Johnson (JNJ) responsible. The Trump Administration has decided to restrict access to opioids by federal employees. The noose is tightening on the opioid industry.
Companies on the verge of approvals for this class of drugs are getting hit in the backlash. The latest is Nektar Therapeutics (NASDAQ:NKTR). The FDA just postponed an advisory committee meeting for